Passage BIO, Inc. (PASG) AI Dilution Summary

Estimated cash was $24,155,000 as of 2026-06-30, the same as cash at the 2026-06-30 balance-sheet date, against estimated monthly burn of $3,060,333. Funding runs through the active ATM with Cowen and Company, LLC (TD Cowen; TD Securities (USA) LLC as successor), authorised to $125,000,000; the most recent capital raised was ATM sales through 2026-06-30, with later sales not yet reported.